Moxetumomab pasudotox and Scopolamine Transdermal Patch
Determining the interaction of Moxetumomab pasudotox and Scopolamine Transdermal Patch and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: scopolamine
Brand name: Transderm-Scop
Synonyms: Scopolamine transdermal, Scopolamine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Scot-Tussin Allergy Relief Formula
- Moxetumomab pasudotox-Scot-Tussin Diabetic
- Moxetumomab pasudotox-Scot-Tussin DM
- Moxetumomab pasudotox-Scot-Tussin Sugar Free DM
- Moxetumomab pasudotox-Scytera
- Moxetumomab pasudotox-SE 10-5 SS Cream
- Scopolamine Transdermal Patch-Moxetumomab Pasudotox-tdfk
- Scopolamine Transdermal Patch-Moxetumomab pasudotox-tdfk Intravenous
- Scopolamine Transdermal Patch-Moxifloxacin
- Scopolamine Transdermal Patch-Moxifloxacin (Systemic)
- Scopolamine Transdermal Patch-Moxifloxacin Hydrochloride
- Scopolamine Transdermal Patch-Moxifloxacin Injection